TMO
★★☆☆☆ PassmistralThermo Fisher Scientific Inc.
Healthcare · sector percentile 46
세션 움직임
$628.74
거래량 0.92× 평균
54/100 quant · tgt $631.42
ADV$ 1117.1M
세션 2026-08-24 · 스냅샷 — 실시간 호가 아님
직전 스캔 대비
2026-08-21 → 2026-08-25
참고용이며 매수/매도 신호가 아닙니다. 스캔 이력과 캐시된 뉴스·공시로 구성됩니다.
스냅샷 시세
세션 2026-08-24 · 스캔 2026-08-25 · 푸시 08-24 18:17 ET · 애프터아워 (오래됨)
시세 상세 보기시세 상세 숨기기
- 종가/스캔가
- $628.74
- 전일 종가
- $629.27
- 푸시 최신가
- $628.74 (오래됨) · 08-24 18:17 ET · 애프터아워
- 세션 시가
- $630.00
- 직전 세션 범위
- $615.97 – $629.11
- 52주 범위
- $556.01 – $634.70
- 세션 거래량
- 1,727,016
- 평균 거래량 (20일)
- 1,883,681
- 시가총액
- $232.47B
- PER (TTM)
- 33.89
- Forward PER
- 22.85
- 배당 수익률
- 0.29%
- 1년 목표가 추정
- $631.42
- 다음 실적
- 2026-10-21
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes. 프리/애프터 시세는 유동성이 얇아 정규장과 다를 수 있습니다.
시장 브리핑
선별된 요약입니다 — 매매 신호가 아닙니다. 헤드라인·링크는 제공된 그대로 표시됩니다.
이 종목의 최근 헤드라인이 없습니다.
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — Thermo Fisher’s dominant Life Sciences portfolio and recurring revenue (60%+ recurring) underpin resilient growth even in macro downturns, with high-margin instrument and consumables segments driving FCF margins above 13%.
- Risks — Regulatory scrutiny on lab equipment pricing and potential reimbursement cuts in Europe/Asia could compress gross margins, offsetting volume gains.
- Target Upside — Consensus target of $631 implies ~0.4% upside from current $628.74, reflecting modest valuation expansion despite strong fundamentals.
Score History
16 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-08-25$628.74+$1.1954.2Pass
- 2026-08-21$627.55+$14.0154.1Pass
- 2026-08-20$613.54+$24.5054.9Pass
- 2026-08-19$589.04+$3.5356.5Pass
- 2026-08-18$585.51−$2.7856.7Pass
- 2026-08-17$588.29−$7.6056.9Pass
- 2026-08-14$595.89+$0.5556.0Pass
- 2026-08-13$595.34−$9.6656.0Pass
- 2026-08-12$605.00+$5.3155.4Pass
- 2026-08-11$599.69+$19.6756.0Pass
- 2026-08-07$580.02+$2.1956.8Pass
- 2026-08-06$577.83+$13.0857.3Pass
- 2026-08-05$564.75−$9.2858.3Pass
- 2026-08-03$574.03−$0.2757.5Pass
- 2026-08-01$574.30+$3.4557.4Pass
- 2026-07-31$570.85—57.3Pass
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 49.1%
- vs 20d (z)
- 0.66
- Short vol
- 374,310
- Status
- ok
Squeeze pressure score
full34/100
- Short leg
- 33
- Call leg
- 45
- Activity
- 1.7
- Call vol share
- 45.1%
- PCR (vol)
- 1.22
- Call OI share
- 50.0%
- ATM IV
- 0.4%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
공시 점수 (Disclosure)
캐시된 SEC 공시 기반 News / Insider / Earnings 규칙 다리 — 참고용이며, beat/miss나 매수 신호가 아닙니다.
점수 창에 최근 SEC 공시·실적 일정 입력이 아직 없습니다.
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
실적 서프라이즈 (퀀트 맥락)
최근 퀀트 스캔에 캐시된 Yahoo/공개 펀더멘털 수치입니다 — 공시 이벤트 점수에 합산되지 않으며 매수 신호가 아닙니다. 최신 발표보다 늦을 수 있습니다.
최근 보고 서프라이즈 +0.1%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-21yahoo_calendar
- Last earnings
- —
- SEC ↗42026-08-24
FORM 4
- SEC ↗42026-08-24
FORM 4
- SEC ↗42026-08-20
FORM 4
- SEC ↗42026-08-13
FORM 4
- SEC ↗42026-08-10
FORM 4
- SEC ↗42026-08-10
FORM 4
- SEC ↗42026-08-07
FORM 4
- SEC ↗42026-08-07
FORM 4
- SEC ↗42026-08-07
FORM 4
- SEC ↗10-Q2026-07-31
10-Q
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.